OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Geralyn Ritter is head of external affairs and ESG at Organon. In this role, she focuses on guiding and shaping how the company interacts with key stakeholders and the environment.
Nevertheless, it’s time to reassess how to leverage for greatest impact.
Drug access leads list of issues raised by pharma shareholders.
There is room to improve what good looks like across the industry.
Examining efforts to boost women representation on company boards.
The validity of ESG-driven investment and reporting in healthcare.
How principles of both can help companies navigate future storms.